Catalyst Wire Dossier Catalyst Wire Dossier

Arabinoxylan-Oligosaccharides

arabinoxylan-oligosaccharides · KU Leuven
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Arabinoxylan-Oligosaccharides, covering 2009-02-27 to 2015-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome [NA]

See pricing